Congress Asset Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $373K | Sell |
1,916
-978
| -34% | -$203K | ﹤0.01% | 344 |
|
|
2026
Q1 | $650K | Sell |
2,894
-843
| -23% | -$210K | ﹤0.01% | 361 |
|
|
2025
Q4 | $900K | Sell |
3,737
-2,890
| -44% | -$739K | 0.01% | 318 |
|
|
2025
Q3 | $1.81M | Buy |
6,627
+1,637
| +33% | +$447K | 0.01% | 289 |
|
|
2025
Q2 | $1.29M | Sell |
4,990
-484,773
| -99% | -$116M | 0.01% | 307 |
|
|
2025
Q1 | $110M | Sell |
489,763
-34,196
| -7% | -$7.98M | 0.82% | 39 |
|
|
2024
Q4 | $120M | Sell |
523,959
-43,509
| -8% | -$10.5M | 0.81% | 45 |
|
|
2024
Q3 | $139M | Sell |
567,468
-4,819
| -0.8% | -$1.08M | 0.94% | 31 |
|
|
2024
Q2 | $110M | Sell |
572,287
-11,923
| -2% | -$2.42M | 0.79% | 54 |
|
|
2024
Q1 | $116M | Buy |
584,210
+6,231
| +1% | +$1.14M | 0.83% | 57 |
|
|
2023
Q4 | $99.4M | Buy |
577,979
+48,523
| +9% | +$7.46M | 0.78% | 59 |
|
|
2023
Q3 | $78.3M | Sell |
529,456
-13,698
| -3% | -$2.48M | 0.69% | 72 |
|
|
2023
Q2 | $119M | Sell |
543,154
-4,607
| -0.8% | -$1.03M | 1.03% | 28 |
|
|
2023
Q1 | $120M | Buy |
547,761
+6,452
| +1% | +$1.4M | 1.12% | 28 |
|
|
2022
Q4 | $113M | Sell |
541,309
-15,818
| -3% | -$3.48M | 1.13% | 21 |
|
|
2022
Q3 | $122M | Sell |
557,127
-10,436
| -2% | -$2.38M | 1.3% | 12 |
|
|
2022
Q2 | $119M | Sell |
567,563
-8,509
| -1% | -$1.81M | 1.14% | 20 |
|
|
2022
Q1 | $140M | Buy |
576,072
+38
| +0% | +$9.19K | 1.19% | 20 |
|
|
2021
Q4 | $150M | Sell |
576,034
-8,919
| -2% | -$2.31M | 1.14% | 30 |
|
|
2021
Q3 | $154M | Sell |
584,953
-6,593
| -1% | -$1.8M | 1.2% | 25 |
|
|
2021
Q2 | $146M | Sell |
591,546
-9,020
| -2% | -$1.9M | 1.22% | 22 |
|
|
2021
Q1 | $117M | Sell |
600,566
-18,591
| -3% | -$3.73M | 1.05% | 36 |
|
|
2020
Q4 | $132M | Sell |
619,157
-3,632
| -0.6% | -$724K | 1.24% | 23 |
|
|
2020
Q3 | $107M | Sell |
622,789
-28,407
| -4% | -$5.25M | 1.16% | 32 |
|
|
2020
Q2 | $125M | Sell |
651,196
-38,026
| -6% | -$6.22M | 1.49% | 11 |
|
|
2020
Q1 | $102M | Sell |
689,222
-66,169
| -9% | -$10.5M | 1.55% | 9 |
|
|
2019
Q4 | $117M | Sell |
755,391
-37,296
| -5% | -$5.38M | 1.43% | 9 |
|
|
2019
Q3 | $107M | Sell |
792,687
-59,640
| -7% | -$7.81M | 1.38% | 9 |
|
|
2019
Q2 | $104M | Sell |
852,327
-27,139
| -3% | -$3.01M | 1.32% | 16 |
|
|
2019
Q1 | $91.4M | Sell |
879,466
-18,536
| -2% | -$1.91M | 1.2% | 28 |
|
|
2018
Q4 | $102M | Sell |
898,002
-65,069
| -7% | -$6.97M | 1.54% | 3 |
|
|
2018
Q3 | $111M | Sell |
963,071
-26,486
| -3% | -$2.9M | 1.44% | 7 |
|
|
2018
Q2 | $102M | Sell |
989,557
-39,759
| -4% | -$4.02M | 1.41% | 9 |
|
|
2018
Q1 | $101M | Sell |
1,029,316
-49,329
| -5% | -$4.66M | 1.43% | 5 |
|
|
2017
Q4 | $91.3M | Buy |
1,078,645
+23,714
| +2% | +$1.96M | 1.33% | 13 |
|
|
2017
Q3 | $81.2M | Buy |
1,054,931
+38,866
| +4% | +$2.97M | 1.26% | 16 |
|
|
2017
Q2 | $79.1M | Buy |
1,016,065
+90,660
| +10% | +$6.49M | 1.42% | 12 |
|
|
2017
Q1 | $66.6M | Buy |
925,405
+60,609
| +7% | +$4.19M | 1.27% | 18 |
|
|
2016
Q4 | $53.7M | Buy |
864,796
+142,056
| +20% | +$8.7M | 1.12% | 34 |
|
|
2016
Q3 | $46.8M | Buy |
722,740
+53,083
| +8% | +$3.53M | 1.03% | 45 |
|
|
2016
Q2 | $42.3M | Buy |
669,657
+59,227
| +10% | +$3.49M | 0.98% | 46 |
|
|
2016
Q1 | $35.3M | Buy |
+610,430
| New | +$34.6M | 0.85% | 56 |
|
Other funds holding RMD
AT
CIM
AC
MPWT
NAM
CNB
LTAS
Congress Asset Management's RMD Position: Q2 2026 in Review
Congress Asset Management reduced its ResMed (RMD) stake by 34% in Q2 2026, selling an estimated $203K and leaving 1,916 shares worth $373K. The position accounts for ﹤0.01% of the portfolio, ranked #344.
Congress Asset Management first reported a position in RMD in Q1 2016 and has held it in 42 quarters since. The position peaked at $154M in Q3 2021. 126 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Congress Asset Management held 1,916 shares of ResMed worth $373K as of Q2 2026.
- Congress Asset Management sold 978 ResMed shares in Q2 2026, an estimated $203K.
- ResMed made up ﹤0.01% of Congress Asset Management's portfolio in Q2 2026, its #344 holding.
- Congress Asset Management first reported a position in ResMed in Q1 2016 and has held it in 42 quarters since.
- Congress Asset Management's ResMed position peaked at $154M in Q3 2021.
- 126 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Congress Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.